1474 related articles for article (PubMed ID: 9328334)
1. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Mol Biol Rep; 1996; 23(3-4):235-42. PubMed ID: 9112234
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Baillieres Clin Gastroenterol; 1996 Sep; 10(3):501-32. PubMed ID: 8905121
[TBL] [Abstract][Full Text] [Related]
4. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
5. Viral induction of autoimmunity: mechanisms and examples in hepatology.
Manns MP; Obermayer-Straub P
J Viral Hepat; 1997; 4 Suppl 2():42-7. PubMed ID: 9429209
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
8. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
9. High levels of autoantibodies against drug-metabolizing enzymes in SLA/LP-positive AIH-1 sera.
Shinoda M; Tanaka Y; Kuno T; Matsufuji T; Matsufuji S; Murakami Y; Mizutani T
Autoimmunity; 2004; 37(6-7):473-80. PubMed ID: 15621574
[TBL] [Abstract][Full Text] [Related]
10. Hepatotropic viruses and autoimmunity 1997.
Manns MP
J Viral Hepat; 1997; 4 Suppl 1():7-10. PubMed ID: 9097272
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.
Strassburg CP; Obermayer-Straub P; Alex B; Durazzo M; Rizzetto M; Tukey RH; Manns MP
Gastroenterology; 1996 Dec; 111(6):1576-86. PubMed ID: 8942737
[TBL] [Abstract][Full Text] [Related]
12. Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s.
Bogdanos DP; Dalekos GN
Curr Med Chem; 2008; 15(22):2285-92. PubMed ID: 18781950
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
[TBL] [Abstract][Full Text] [Related]
15. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of autoantigens in hepatitis D.
Philipp T; Straub P; Durazzo M; Tukey RH; Manns MP
J Hepatol; 1995; 22(1 Suppl):132-5. PubMed ID: 7602065
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
20. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]